Kayentis is a company that develops electronic clinical outcome assessment (eCOA) technology. Its solution helps with electronic data capture for patients in clinical trials and offers a range of tools that are used together and adaptable for all clinical study needs.
|Employees (est.) (Oct 2020)||126||(-1%)|
Kayentis total Funding
Kayentis latest funding size
Time since last funding
|4 years ago|
|XAnge Private Equity, Seventure Partners, Innovation Capital, Lavauzelle, Xange, KCE, Extens|
Kayentis has 447 Twitter Followers. The number of followers has decreased 0.6% month over month and decreased 0.8% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Kayentis founded?
Kayentis was founded in 2004.
Who are Kayentis key executives?
Kayentis's key executives are Guillaume Juge, Estelle Haenel and Estelle Bonelli.
How many employees does Kayentis have?
Kayentis has 126 employees.
Who are Kayentis competitors?
Competitors of Kayentis include Antipodean Pharmaceuticals, ReCept Pharmacy and Iterum Therapeutics.
Where is Kayentis headquarters?
Kayentis headquarters is located at 19 Chemin du Vieux Chêne, Meylan.
Where are Kayentis offices?
Kayentis has offices in Meylan, Boston and Minato City.
How many offices does Kayentis have?
Kayentis has 3 offices.
Receive alerts for 300+ data fields across thousands of companies